Skip to content

Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine

Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese Medicine and Western Medicine Based on Multi-omics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06528197
Enrollment
1000
Registered
2024-07-30
Start date
2024-07-04
Completion date
2026-12-31
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Sjögren Syndrome

Brief summary

This study aims to establish a large sample cohort of patients with primary sjogren's syndrome, collect multi-omics information of patients with primary sjogren's syndrome, and construct disease diagnosis model and disease prognosis prediction model.

Interventions

None listed

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
CollaboratorOTHER
Beijing Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital
CollaboratorUNKNOWN
China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren's syndrome.

Exclusion criteria

* Comorbid connective tissue disease other than the disease under research. * Women who are pregnant or breastfeeding. * Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure, or severe malignant tumors. * Other conditions (e.g., cognitive impairment) that the investigators consider ineligible for enrollment.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with system involvementBaseline , 6 months follow-upSystem involvement determined from clinical diagnosis

Secondary

MeasureTime frameDescription
MortalityBaseline , 6 months follow-upAll-cause mortality
Number of participants with tumorBaseline , 6 months follow-upTumor determined from clinical diagnosis
Number of participants with connective tissue diseaseBaseline , 6 months follow-upConnective tissue disease determined from clinical diagnosis

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026